PhD, neuropsychologist | Research Fellow @MGHNeurology & @HarvardMed | Alzheimer’s disease, cognition, measurement, remote mobile testing, learning & memory
Sep 12, 2022 • 4 tweets • 3 min read
Our perspective article on cognitive outcome measures for #AlzheimersDisease clinical trials is out! doi.org/10.1002/alz.12… We aimed to provide a framework to advance the design and implementation of (more) suitable measures to assess clinical efficacy in early AD trials.(1/4)👇
Based on lessons learned from previous AD trials, and leveraging the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology, we provide recommendations to evaluate performance-based cognitive tests for AD clinical trials (Table 2).(2/4)